These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30412596)

  • 81. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
    Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
    Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses.
    Li X; Tse VC; Lau WC; Cheung BM; Lip GY; Wong IC; Chan EW
    PLoS One; 2016; 11(6):e0157129. PubMed ID: 27362421
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
    Patel B; Peiris DP; Patel A; Jan S; Harris MF; Usherwood T; Panaretto K; Lung T
    Med J Aust; 2020 Jul; 213(2):73-78. PubMed ID: 32594567
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia.
    Visconti AJ; Doyle JS; Weir A; Shiell AM; Hellard ME
    J Gastroenterol Hepatol; 2013 Apr; 28(4):707-16. PubMed ID: 23173753
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
    Ademi Z; Pasupathi K; Liew D
    Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF; Rind DM; Fazioli K; Chapman RH; Pearson SD; Hansen RN
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [No Abstract]   [Full Text] [Related]  

  • 89. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension.
    Liao CT; Toh HS; Sun L; Yang CT; Hu A; Wei D; Melgarejo J; Zhang ZY
    JAMA Netw Open; 2023 Feb; 6(2):e230708. PubMed ID: 36848091
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator price.
    Kim H; Goodall S; Liew D
    J Med Econ; 2021; 24(1):893-899. PubMed ID: 34259119
    [No Abstract]   [Full Text] [Related]  

  • 92. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy.
    Michaeli DT; Michaeli JC; Boch T; Michaeli T
    Clin Drug Investig; 2022 Aug; 42(8):643-656. PubMed ID: 35819632
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cost-utility analysis of an alcohol policy in Thailand: a case study of a random breath testing intervention.
    Vichitkunakorn P; Khampang R; Leelahavarong P; Nontarak J; Assanangkornchai S
    BMC Health Serv Res; 2024 Jun; 24(1):739. PubMed ID: 38886718
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation.
    Latimer NR; Bhadhuri A; Alshreef A; Palmer R; Cross E; Dimairo M; Julious S; Cooper C; Enderby P; Brady MC; Bowen A; Bradley E; Harrison M
    Clin Rehabil; 2021 May; 35(5):703-717. PubMed ID: 33233972
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain.
    Karády J; Mayrhofer T; Ivanov A; Foldyna B; Lu MT; Ferencik M; Pursnani A; Salerno M; Udelson JE; Mark DB; Douglas PS; Hoffmann U
    JAMA Netw Open; 2020 Dec; 3(12):e2028312. PubMed ID: 33315111
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The cost-effectiveness of the MobileMums intervention to increase physical activity among mothers with young children: a Markov model informed by a randomised controlled trial.
    Burn E; Marshall AL; Miller YD; Barnett AG; Fjeldsoe BS; Graves N
    BMJ Open; 2015 Apr; 5(4):e007226. PubMed ID: 25926145
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
    Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
    Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population.
    Jülicher P; Makarova N; Ojeda F; Giusepi I; Peters A; Thorand B; Cesana G; Jørgensen T; Linneberg A; Salomaa V; Iacoviello L; Costanzo S; Söderberg S; Kee F; Giampaoli S; Palmieri L; Donfrancesco C; Zeller T; Kuulasmaa K; Tuovinen T; Lamrock F; Conrads-Frank A; Brambilla P; Blankenberg S; Siebert U
    PLoS One; 2024; 19(7):e0307468. PubMed ID: 39028718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.